EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A BRAF-activated noncoding RNA attenuates clear cell renal cell carcinoma via repression of glucose-6-phosphate dehydrogenase

Wenjing Liu, Yueli Ni, Honggang Bai, Xiangjie Liu, Asif Shahzad, Kun Cui, Qiuxin Duan, Ziyuan Bai, Yurong Dong, Zihan Yi, Buqing Sai, Yingmin Kuang und 4 weitere

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.108247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Wenjing Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Kunming Medical University, Yunnan, Kunming, PR China. Hauptthemen laut MEDLINE: Glucosephosphate Dehydrogenase, Carcinoma, Renal Cell, Kidney Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Basic Research Foundation of Yunnan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is a disease rooted in metabolic disorders, distinguished by abnormally high activity of glucose 6-phosphate dehydrogenase (G6PD). G6PD serves as a key rate-limiting enzyme in the pentose phosphate pathway. Meanwhile, BRAF-activated noncoding RNA (BANCR) has emerged as a crucial regulatory factor linked to various cancers. The expression pattern of BANCR varies across different cancer types, exhibiting apparent duality in its function. However, the precise role and underlying mechanisms of BANCR in ccRCC tumorigenesis remain incompletely understood. Our study indicated that BANCR was downregulated in ccRCC and influenced cell survival by modulating cell proliferation, apoptosis, and G6PD enzyme activity. The underlying mechanism was that BANCR could directly bind to G6PD through a long noncoding RNA-protein interaction, ultimately inhibiting G6PD activity by impeding its dimer formation. Moreover, BANCR exhibited the capability to modulate the glucose metabolic flow in ccRCC cells. Subsequent experiments demonstrated a significant inhibition of tumor growth in vivo upon overexpression of BANCR, and G6PD played a pivotal role in mediating the tumor-suppressive effect of BANCR in ccRCC cells. In conclusion, this study provides novel insights into the molecular pathogenesis of ccRCC, highlights a distinct and new regulatory mechanism responsible for the ectopic overactivation of G6PD in ccRCC progression, and suggests that BANCR-mediated suppression of G6PD activity could emerge as a potential therapeutic strategy for ccRCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucosephosphate DehydrogenaseCarcinoma, Renal CellKidney NeoplasmsRNA, Long NoncodingProto-Oncogene Proteins B-rafHumansAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticMiceApoptosisMice, Nude

Stichwörter der Autor:innen

BANCRG6PDccRCCdimer formationglucose metabolic flow

Substanzen

Glucosephosphate DehydrogenaseRNA, Long NoncodingProto-Oncogene Proteins B-rafBANCR long non-coding RNA, humanG6PD protein, humanBRAF protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Kunming Medical University, Yunnan, Kunming, PR China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Kunming Medical University, Yunnan, Kunming, PR China; Department of Clinical Laboratory, The Second Hospital of Jingzhou, Jingzhou, Hu…
  • Department of Pathology, The First Affiliated Hospital of Kunming Medical University, Yunnan, Kunming, PR China.
  • Department of Medical Oncology, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Yunnan, Kunming, PR China.
  • Department of Organ Transplantation, The First Affiliated Hospital of Kunming Medical University, Yunnan, Kunming, PR China.
  • Greater Bay Biomedical InnoCenter, Shenzhen Bay Laboratory, Shenzhen, PR China. Electronic address: guochen@szbl.ac.cn.

Förderung

  • Applied Basic Research Foundation of Yunnan Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, W., Ni, Y., Bai, H., Liu, X., Shahzad, A., Cui, K., Duan, Q., Bai, Z., Dong, Y., Yi, Z., Sai, B., Kuang, Y., Guo, C., Zhu, Y., Zhang, Q., & Yang, Z. (2025). A BRAF-activated noncoding RNA attenuates clear cell renal cell carcinoma via repression of glucose-6-phosphate dehydrogenase. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.108247

Vancouver

Liu W, Ni Y, Bai H, Liu X, Shahzad A, Cui K, et al. A BRAF-activated noncoding RNA attenuates clear cell renal cell carcinoma via repression of glucose-6-phosphate dehydrogenase. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.108247

BibTeX
@article{Liu2025,
  author = {Liu, Wenjing and Ni, Yueli and Bai, Honggang and Liu, Xiangjie and Shahzad, Asif and Cui, Kun and Duan, Qiuxin and Bai, Ziyuan and Dong, Yurong and Yi, Zihan and Sai, Buqing and Kuang, Yingmin and Guo, Chen and Zhu, Yuechun and Zhang, Qiao and Yang, Zhe},
  title = {A BRAF-activated noncoding RNA attenuates clear cell renal cell carcinoma via repression of glucose-6-phosphate dehydrogenase},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.108247}
}
Kostenlos starten →